跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ERIBULINA BAXTER 0,44 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
ERIBULINA BAXTER 0,44 MG/ML SOLUCION INYECTABLE EFG
Baxter Holding B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 15, 2024
Approval ID
898419d66273d580
Company
Baxter Holding B.V.
Type
Standard
Approval Details
Approval Id
898419d66273d580
Drug Cima Aemps Name
ERIBULINA BAXTER 0,44 MG/ML SOLUCION INYECTABLE EFG
Register Number
1241819001
Holder Company Name
Baxter Holding B.V.
Marketing Company Name
Baxter S.L.
Holder Company Detail Path
/organization/baxter-holding-bv
Authorization Date
2024-07-15
Dosage Form
SOLUCIÓN INYECTABLE
Dose
0,44 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Baxter Holding B.V.
Company Detail Path
/organization/baxter-holding-bv
Company Information
Pharmaceutical Company Name
Baxter Holding BV
Country Name
Netherlands
Active Ingredients
ERIBULINA MESILATO
1 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 15, 2024
Approval ID
898419d66273d580
Type
Standard
Back to CIMA-AEMPS Approvals
ERIBULINA BAXTER 0,44 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
